KOD News and Press, Kodiak Sciences Inc From 11/08/23

Kodiak Sciences Inc (KOD) is expected to report $-1.41 for Q3 2023

2023-11-07 08:36:07 ET Losers: Ventyx Biosciences ( VTYX ) -76% announces results from the phase 2 trial of VTX958 in patients with moderate to severe plaque Psoriasis and provides corporate update. Alto Ingredients ( ALTO ) -50% reports third quarter 2023 re...

2023-11-06 08:17:52 ET Losers: MoonLake Immunotherapeutics ( MLTX ) -30% . Tecnoglass ( TGLS ) -15% after Q3 earning release . Kodiak Sciences ( KOD ) -11% says Phase 3 trial for lead asset met key goals. Arrival ( ARVL ) -9% . A...

2023-11-06 07:00:44 ET More on Kodiak Sciences Kodiak's Uncertain Path: Reallocating The Cash Reserve (Rating Downgrade) Kodiak Sciences CMO resigns following failed Phase 3 studies for lead drug Seeking Alpha’s Quant Rating on Kodiak Sciences Historic...

2023-11-03 08:22:27 ET More on pre-market losers stock Stocks To Watch: Tesla, Netflix, And AT&T Headline Big Week Of Earnings Acurx Pharma falls after mid-stage data for lead asset AstraZeneca to invest $245M in Cellectis to strengthen gene therapy portfolio ...

2023-11-02 13:15:49 ET More on etc. Dynatrace, Inc. (DT) Q2 2024 Earnings Call Transcript Geron Corporation 2023 Q3 - Results - Earnings Call Presentation Gates Industrial: Encouraging Q3 Report Needed To Finally Create A Floor For The Stock Icahn Enterprises...

2023-11-02 12:16:20 ET DENVER, Colo., Nov. 2, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Palantir Technologies Inc (NYSE: PLTR), Panbela Therapeutics Inc (NASDAQ: PBLA), Joby Aviation Inc (NYS...

2023-11-02 10:01:01 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in F...

KODIAK SCIENCES ANNOUNCES FIRST TIME PRESENTATION OF PRIMARY ENDPOINT DATA FROM TARCOCIMAB TEDROMER PHASE 3 GLOW STUDY IN PATIENTS WITH DIABETIC RETINOPATHY AT AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING PR Newswire PALO ALTO, Calif. , Nov. 1, 2023 /PRNewswi...

(NewsDirect) Kodal Minerals CEO Bernard Aylward joined Proactive's Stephen Gunnion with news that the company has agreed terms with Hainan Mining to complete the funding package for the Bougouni Lithium Project in Mali. The news sent Kodal's shares 24.5% higher by the close of trade i...